Unit 3.

Quinn Karylle Fuentes · 28問 · 2年前

通報

問題一覧

assigned to each batch received from the supplier.

Receiving number.

A receiving number - distinct. RTR (Receiving Tally Report) is completed upon receipt of material (T/F.)

True.

amount and type of finished goods or raw materials when a shipment has been accepted

Receiving tally report.

Completed upon receipt of material

Receiving tally report.

The receiving tally report is checked by a QC inspector for accuracy (t/F)

True.

Rtr should be prepared foe every shipment (T/F)

True.

After visual examination of containers

Sampling.

The RTR is prepared in the warehouse by the warehouse personnel who is responsible for assigning a receiving number to the material. The shipment is held in quarantine pending quality control approval (T/F)

True.

Characteristics of the material based on visual inspection, and tests using senses. These are performed to determine conformance to specifications for properties that can be checked by appearance, odor, or flavor

Organoleptic information.

Used as an aid in verifying the identity of articles as they are purported to be, e.g., those taken from labeled contain and to establish whether it is the article named in USP–NF

Identification test.

Determination of strength, potency, or purity of the material.

Assay.

Tests to limit such substance to amounts that are unobjectionable under conditions in which the article is customarily employed. It may be chemical, physical, or microbiological.

Imits of impurities and foreign substance.

Determines the presence of living organisms that compromise the quality of the material such as pathogens, spoilage organisms, or indicators of poor sanitation, including total plate count, yeast, mold, and coliform

Microbial test.

660

Glass containers.

661

containers plastic.

87.

in vitro

in vivo.

Bacterial endotoxins testing.

Neutral glass, borosilicate (80% silica, 10% boric oxide, and a small amount of sodium oxide and aluminum oxide

Type 1.

It is chemically inert, has the lowest coefficient or expansion, and has an excellent thermal shock properties. It possesses a high hydrolytic resistance

Type 1 highly resistance.

Soda-lime (consisting of 75% silica, sodium oxide, calcium oxide, and a small fraction of aluminum oxide, potassium oxide)

Type 2.

This glass container has been treated with sulfur to eliminate leachable oxides. This glass has a lower melting point than Type 1 glass, thus, easier to produce and consequently cheaper

Type 2.

High hydrolytic resistance due to surface treatment of the glass.

Type 2.

High hydrolytic resistance due to surface treatment of the glass.

Internal reflectance test.

This standard determines endotherms and exotherm temperatures. These temperatures should fall within the ranges specified by the standard.

Thermal analysis.

These tests are intended to protect from light as specified by the standard. This determines the effect of light passing through the bottle wall on the product stability

Light transmission.

These tests are intended to protect from moisture permeation as specified by the standard à stability of the product

Water vapor permeation.

Monthly or before use vitamin and flavoring.

6 months.

Monthly or before use- active ingredients, dyes

12 months.

Monthly or before use of excipients.

24 months.

Based on the stability of raw materials, the re-assay dates assigned

Re assay date.

Water bottle, caps and jar.

1.) polyethylene terephthalate.

Shampoo bottle's, Grocery bags.

2.) High density polyethylene.

Cleaning products and sheeting

3.) Polyvinyl chloride.

Bread bags

4.) Low density polyethylene.

Yogurt cups

5.) Polypropylene.

Straws and hanger.

5.) Polypropylene.

take away and hard packaging toys.

6.) Polystyrene.

baby nylon and cds.

7.) Others.

Cell structure.

Cell structure.

28問 • 2年前

Quinn Karylle Fuentes · 29問 · 2年前

Electrolytes and non electrolytes

Electrolytes and non electrolytes

29問 • 2年前

Quinn Karylle Fuentes · 45問 · 2年前

45問 • 2年前

Quinn Karylle Fuentes · 38問 · 2年前

POST LAB (EXP 4)

POST LAB (EXP 4)

38問 • 2年前

Density and specific gravity

Density and specific gravity

Quinn Karylle Fuentes · 18問 · 2年前

FORCES OF ATTRACTION

FORCES OF ATTRACTION

18問 • 2年前

Quinn Karylle Fuentes · 63問 · 2年前

Microbial growth

Microbial growth

63問 • 2年前

Quinn Karylle Fuentes · 61問 · 2年前

Introduction.

Introduction.

61問 • 2年前

Quinn Karylle Fuentes · 97問 · 2年前

Microbial control.

Microbial control.

97問 • 2年前

Quinn Karylle Fuentes · 100問 · 2年前

States of matter

States of matter

100問 • 2年前

Quinn Karylle Fuentes · 86問 · 2年前

Introduction.

Introduction.

86問 • 2年前

Quinn Karylle Fuentes · 77問 · 2年前

Drug development.

Drug development.

77問 • 2年前

Quinn Karylle Fuentes · 9問 · 2年前

CGMP

CGMP

9問 • 2年前

Quinn Karylle Fuentes · 24問 · 2年前

Pharmaceutical ingredients.

Pharmaceutical ingredients.

24問 • 2年前

Quinn Karylle Fuentes · 43問 · 2年前

Powdered & granules

Powdered & granules

43問 • 2年前

Quinn Karylle Fuentes · 24問 · 2年前

Capsule.

Capsule.

24問 • 2年前

Quinn Karylle Fuentes · 23問 · 2年前

Tablets.

Tablets.

23問 • 2年前

Quinn Karylle Fuentes · 66問 · 2年前

Calculatiom of dose

Calculatiom of dose

66問 • 2年前

Quinn Karylle Fuentes · 29問 · 2年前

Postlab 5&6

Postlab 5&6

29問 • 2年前

Quinn Karylle Fuentes · 33問 · 2年前

COLLIGATIVE PROPERTIES.

COLLIGATIVE PROPERTIES.

33問 • 2年前

Quinn Karylle Fuentes · 69問 · 2年前

SEMI SOLID

SEMI SOLID

69問 • 2年前

Quinn Karylle Fuentes · 60問 · 2年前

Basic immunology

Basic immunology

60問 • 2年前

Quinn Karylle Fuentes · 62問 · 2年前

Basic immunology (2)

Basic immunology (2)

62問 • 2年前

Quinn Karylle Fuentes · 44問 · 2年前

Transdermal

Transdermal

44問 • 2年前

Quinn Karylle Fuentes · 43問 · 2年前

Distribution.

Distribution.

43問 • 2年前

Quinn Karylle Fuentes · 65問 · 2年前

Infectious disease.

Infectious disease.

65問 • 2年前

Quinn Karylle Fuentes · 79問 · 2年前

Infectious diseases (2)

Infectious diseases (2)

79問 • 2年前

Gram positive ( Bacteriology)

Gram positive ( Bacteriology)

All topic. ( Compressed.)

All topic. ( Compressed.)

Quinn Karylle Fuentes · 30問 · 2年前

All topic ( Compressed)

All topic ( Compressed)

30問 • 2年前

Quinn Karylle Fuentes · 13問 · 2年前

All topics (compressed)

All topics (compressed)

13問 • 2年前

Quinn Karylle Fuentes · 28問 · 2年前

Exercise 6 ; Isotonic solution.

Exercise 6 ; Isotonic solution.

28問 • 2年前

Quinn Karylle Fuentes · 16問 · 2年前

Exercise 5 : Buffers.

Exercise 5 : Buffers.

16問 • 2年前

Quinn Karylle Fuentes · 26問 · 2年前

Exercise 7 : Factors affecting solubility.

Exercise 7 : Factors affecting solubility.

26問 • 2年前

Quinn Karylle Fuentes · 23問 · 2年前

Experiment 8: Disintegration.

Experiment 8: Disintegration.

23問 • 2年前

Experiment 9 ; Interfacial phenomenon and surface tension.

Experiment 9 ; Interfacial phenomenon and surface tension.

EXP 9 : Aromatic ammonia spirit.

EXP 9 : Aromatic ammonia spirit.

EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

Quinn Karylle Fuentes · 20問 · 2年前

EXP 12: ACACIA MUCILAGE

EXP 12: ACACIA MUCILAGE

20問 • 2年前

Quinn Karylle Fuentes · 33問 · 2年前

EXP13&14 : Starch and Barrium sulfate.

EXP13&14 : Starch and Barrium sulfate.

33問 • 2年前

Quinn Karylle Fuentes · 37問 · 2年前

EXP 15 : Liquid petroleum emulsion 1.0

EXP 15 : Liquid petroleum emulsion 1.0

37問 • 2年前

Quinn Karylle Fuentes · 23問 · 2年前

EXP 15: Liquid petroleum emulsion 1.1

EXP 15: Liquid petroleum emulsion 1.1

23問 • 2年前

Enterobacteriaceae

Enterobacteriaceae

Quinn Karylle Fuentes · 28問 · 2年前

Enterobacteriaceae.

Enterobacteriaceae.

28問 • 2年前

Quinn Karylle Fuentes · 31問 · 2年前

LIQUID DOSAGE FORM 1.0

LIQUID DOSAGE FORM 1.0

31問 • 2年前

Quinn Karylle Fuentes · 12問 · 2年前

Liquid dosage form

Liquid dosage form

12問 • 2年前

Quinn Karylle Fuentes · 44問 · 2年前

MICROMERITICS 1.0

MICROMERITICS 1.0

44問 • 2年前

Quinn Karylle Fuentes · 22問 · 2年前

EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

22問 • 2年前

Quinn Karylle Fuentes · 40問 · 2年前

EXP 8 : KIRBY-BAUER TECHNIQUE

EXP 8 : KIRBY-BAUER TECHNIQUE

40問 • 2年前

Quinn Karylle Fuentes · 29問 · 2年前

EXP 9: STAPHYLOCOCCI

EXP 9: STAPHYLOCOCCI

29問 • 2年前

Quinn Karylle Fuentes · 41問 · 2年前

Drug incompatibilities.

Drug incompatibilities.

41問 • 2年前

Quinn Karylle Fuentes · 41問 · 2年前

Drug compatibilities.

Drug compatibilities.

41問 • 2年前

BACTERIOLOGY 3

BACTERIOLOGY 3

Quinn Karylle Fuentes · 30問 · 2年前

BACTERIOLOGY 3

BACTERIOLOGY 3

30問 • 2年前

Quinn Karylle Fuentes · 45問 · 2年前

SUSPENSION.

SUSPENSION.

45問 • 2年前

Quinn Karylle Fuentes · 40問 · 2年前

Colloidal.

Colloidal.

40問 • 2年前

Quinn Karylle Fuentes · 38問 · 2年前

BACTERIOLOGY 4 (Rickettsia)

BACTERIOLOGY 4 (Rickettsia)

38問 • 2年前

Quinn Karylle Fuentes · 44問 · 2年前

BACTERIOLOGY.

BACTERIOLOGY.

44問 • 2年前

Quinn Karylle Fuentes · 32問 · 2年前

Emulsion.

Emulsion.

32問 • 2年前

Quinn Karylle Fuentes · 42問 · 2年前

EMULSION

EMULSION

42問 • 2年前

Quinn Karylle Fuentes · 36問 · 2年前

MEDICAL RELATED PROBLEMS.

MEDICAL RELATED PROBLEMS.

36問 • 2年前

Quinn Karylle Fuentes · 33問 · 2年前

MEDICATION RELATED PROBLEMS.

MEDICATION RELATED PROBLEMS.

33問 • 2年前

Quinn Karylle Fuentes · 30問 · 2年前

Mycology.

Mycology.

30問 • 2年前

Mycology 2.0

Mycology 2.0

Quinn Karylle Fuentes · 15問 · 2年前

15問 • 2年前

Quinn Karylle Fuentes · 25問 · 2年前

ppr

ppr

25問 • 2年前

Quinn Karylle Fuentes · 20問 · 2年前

MEDICAL DEVICES.

MEDICAL DEVICES.

20問 • 2年前

Quinn Karylle Fuentes · 86問 · 1年前

Pharmacokinetics. (1.0)

Pharmacokinetics. (1.0)

86問 • 1年前

Quinn Karylle Fuentes · 100問 · 1年前

Pharmacokinetics (1.1)

Pharmacokinetics (1.1)

100問 • 1年前

Quinn Karylle Fuentes · 19問 · 1年前

Pharmacokinetics (1.2)

Pharmacokinetics (1.2)

19問 • 1年前

Quinn Karylle Fuentes · 17問 · 1年前

Introduction.

Introduction.

17問 • 1年前

Quinn Karylle Fuentes · 76問 · 1年前

Introduction of biochemistry

Introduction of biochemistry

76問 • 1年前

Quinn Karylle Fuentes · 56問 · 1年前

Intro medicanal chemistry.

Intro medicanal chemistry.

56問 • 1年前

Quinn Karylle Fuentes · 75問 · 1年前

Carbohydrates

Carbohydrates

75問 • 1年前

Quinn Karylle Fuentes · 31問 · 1年前

Carbohydrates 1.1

Carbohydrates 1.1

31問 • 1年前

Quinn Karylle Fuentes · 56問 · 1年前

Detect and quality variation.

Detect and quality variation.

56問 • 1年前

Quinn Karylle Fuentes · 98問 · 1年前

INTRODUCTION

INTRODUCTION

98問 • 1年前

Quinn Karylle Fuentes · 15問 · 1年前

lab (1-2)

lab (1-2)

15問 • 1年前

Quinn Karylle Fuentes · 14問 · 1年前

lab 1-2

lab 1-2

14問 • 1年前

Quinn Karylle Fuentes · 45問 · 1年前

Pharmaceutical chemistry.

Pharmaceutical chemistry.

45問 • 1年前

Quinn Karylle Fuentes · 35問 · 1年前

Pharmaceutical chemistry 1.1

Pharmaceutical chemistry 1.1

35問 • 1年前

Quinn Karylle Fuentes · 70問 · 1年前

Histamin and kinins

Histamin and kinins

70問 • 1年前

Quinn Karylle Fuentes · 45問 · 1年前

PUD.

PUD.

45問 • 1年前

Quinn Karylle Fuentes · 61問 · 1年前

61問 • 1年前

Quinn Karylle Fuentes · 67問 · 1年前

Lipids.

Lipids.

67問 • 1年前

Quinn Karylle Fuentes · 71問 · 1年前

lipids.

lipids.

71問 • 1年前

Quinn Karylle Fuentes · 93問 · 1年前

LAB ✨

LAB ✨

93問 • 1年前

Quinn Karylle Fuentes · 87問 · 1年前

Drug discovery.

Drug discovery.

87問 • 1年前

Quinn Karylle Fuentes · 13問 · 1年前

disease of lipids.

disease of lipids.

13問 • 1年前

Quinn Karylle Fuentes · 57問 · 1年前

Intro (identify structure)

Intro (identify structure)

57問 • 1年前

Quinn Karylle Fuentes · 98問 · 1年前

Carbohydrates

Carbohydrates

98問 • 1年前

Quinn Karylle Fuentes · 96問 · 1年前

Dynamic.

Dynamic.

96問 • 1年前

Quinn Karylle Fuentes · 32問 · 1年前

Unit 1

Unit 1

32問 • 1年前